trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Loperamide does not promote central analgesia because it cannot readily cross the blood-brain barrier

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Loperamide acts as a peripherally restricted opioid because active efflux transporters at the blood-brain barrier normally prevent it from entering the central nervous system.

The analysis

The retrieved papers consistently support the claim that loperamide does not readily cross the blood-brain barrier under normal physiological conditions, which restricts its central analgesic effects. Papers [0], [2], and [11] explicitly describe loperamide as a peripherally restricted mu-opioid agonist whose limited central penetration is maintained by P-glycoprotein efflux transport at the blood-brain barrier, causing central effects only when these transporters are inhibited or impaired.

Evidence for · 3
Competitive Substrates for P-Glycoprotein and Organic Anion Protein Transporters Differentially Reduce Blood Organ Transport of Fentanyl and Loperamide: Pharmacokinetics and Pharmacodynamics in Sprague Dawley Rats
Recorded source metadata

Iman A. Elkiweri, Yan Ling Zhang, U. Christians, K. Ng, M. C. Tissot van Patot, T. Henthorn. Competitive Substrates for P-Glycoprotein and Organic Anion Protein Transporters Differentially Reduce Blood Organ Transport of Fentanyl and Loperamide: Pharmacokinetics and Pharmacodynamics in Sprague Dawley Rats. 2009. https://doi.org/10.1213/ane.0b013e31818e0bd1

Demonstrates that loperamide's limited central nervous system penetration and low brain-to-plasma partitioning are normally enforced by active transport mechanisms.

See more details
More for · 2
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
Recorded source metadata

Milica Vulin, Yu Zhong, Bryan J. Maloney, Björn Bauer, Anika M. S. Hartz. Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model. 2023. https://doi.org/10.1186/s12987-023-00470-z

Shows that loperamide's lack of central effects under normal conditions is due to P-glycoprotein efflux at the blood-brain barrier, which fails only when transport is impaired.

Peripherally mediated opioid combination therapy in mouse and pig.
Recorded source metadata

Peterson CD, Larson CM, Bruce DJ, Clements BM, Pflepsen KR, Akgün E, Kitto KF, Lunzer MM, Fairbanks CA, Portoghese PS, Wilcox GL. Peripherally mediated opioid combination therapy in mouse and pig.. 2025. https://doi.org/10.1016/j.jpain.2024.104735

Identifies loperamide as a peripherally restricted mu-opioid agonist that exerts its actions without central nervous system side effects.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8601 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt